Abstract
Transforming growth factor2 (TGFβ2) is a prototypic member of a large superfamily of multifunctional cytokines, and its potential mechanisms of the neuroprotective activity in ischemic stroke and subcellular compartmentalization are largely unknown. The present study investigated TGF-β2 protein expression in hippocampal neuronal cells after transient forebrain ischemia (TFI). TFI was induced in male adult gerbils with bilateral occlusion of both common carotid arteries for 10 minutes. With immunohistochemical methods we observe the expression of TGF-β2 and morphological alternation in Golgi appratus (GA) in different postischemic periods and sham-operation (6 hours, 1, 3 and 7 days). In addition, the subcellular localization of TGF-β2 is determined in trans-Golgi network (TGN) by doublelabeling confocal immunofluorographs with TGN38.The results showed that TGF-β2 persistent express in the ischemic animals and it peaks at 3 days, then decreased 7 days postocclusion. No significant alterations to the GA were noted at the point of 6 hours,1 and 3 days following TFI, but there are a few neurons in which the GA lost the normal network-like configuration and its elements decreased in cortical cells from gerbils survived 7 days postocclusion. In addition, TGF-β2 was colocalized with TGN38 in the TGN after TFI .Taken together, this result suggested that TGF-β2 protein expression increased in neurons after ischemia, which may represent an endogenous adaptative response of the brain damage and its secretion via GA after ischemia is supposed to be beneficial for GA . Furthermore, fragmentation of GA is not common phenomenon in the ischemia, but intact GA structural of neurons is beneficial for cell survival.
Keywords: Ischemia, TGF-β2, golgi apparatus (GA), gerbils, trans-golgi network (TGN), hippocampus, cortical
Current Neurovascular Research
Title: Transient Cerebral Ischemia Leads to TGF-β2 Expression in Golgi Apparatus Organelles
Volume: 5 Issue: 3
Author(s): Zhiping Hu, Jie Fan, Liuwang Zeng, Wei Lu, Xiangqi Tang, Jie Zhang and Ting Li
Affiliation:
Keywords: Ischemia, TGF-β2, golgi apparatus (GA), gerbils, trans-golgi network (TGN), hippocampus, cortical
Abstract: Transforming growth factor2 (TGFβ2) is a prototypic member of a large superfamily of multifunctional cytokines, and its potential mechanisms of the neuroprotective activity in ischemic stroke and subcellular compartmentalization are largely unknown. The present study investigated TGF-β2 protein expression in hippocampal neuronal cells after transient forebrain ischemia (TFI). TFI was induced in male adult gerbils with bilateral occlusion of both common carotid arteries for 10 minutes. With immunohistochemical methods we observe the expression of TGF-β2 and morphological alternation in Golgi appratus (GA) in different postischemic periods and sham-operation (6 hours, 1, 3 and 7 days). In addition, the subcellular localization of TGF-β2 is determined in trans-Golgi network (TGN) by doublelabeling confocal immunofluorographs with TGN38.The results showed that TGF-β2 persistent express in the ischemic animals and it peaks at 3 days, then decreased 7 days postocclusion. No significant alterations to the GA were noted at the point of 6 hours,1 and 3 days following TFI, but there are a few neurons in which the GA lost the normal network-like configuration and its elements decreased in cortical cells from gerbils survived 7 days postocclusion. In addition, TGF-β2 was colocalized with TGN38 in the TGN after TFI .Taken together, this result suggested that TGF-β2 protein expression increased in neurons after ischemia, which may represent an endogenous adaptative response of the brain damage and its secretion via GA after ischemia is supposed to be beneficial for GA . Furthermore, fragmentation of GA is not common phenomenon in the ischemia, but intact GA structural of neurons is beneficial for cell survival.
Export Options
About this article
Cite this article as:
Hu Zhiping, Fan Jie, Zeng Liuwang, Lu Wei, Tang Xiangqi, Zhang Jie and Li Ting, Transient Cerebral Ischemia Leads to TGF-β2 Expression in Golgi Apparatus Organelles, Current Neurovascular Research 2008; 5 (3) . https://dx.doi.org/10.2174/156720208785425693
DOI https://dx.doi.org/10.2174/156720208785425693 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
SUMOylation in Neurological Diseases
Current Molecular Medicine Efficacy and Safety of Sleeping Beauty Transposon-Mediated Gene Transfer in Preclinical Animal Studies
Current Gene Therapy Treatment Options in Alzheimer´s Disease: The GABA Story
Current Pharmaceutical Design Portal Vein Embolization: A Preoperative Approach to Improve the Safety of Major Hepatic Resection
Current Medical Imaging Non-IgE Mediated Food Allergy
Inflammation & Allergy - Drug Targets (Discontinued) Dual Functional Small Molecule Probes as Fluorophore and Ligand for Misfolding Proteins
Current Organic Chemistry Purines and Pyrimidines: Metabolism, Function and Potential as Therapeutic Options in Neurodegenerative Diseases
Current Protein & Peptide Science Pharmacokinetics and Acute Toxicity of a Histone Deacetylase Inhibitor, Scriptaid, and its Neuroprotective Effects in Mice After Intracranial Hemorrhage
CNS & Neurological Disorders - Drug Targets Pityriasis Rosea: An Updated Review
Current Pediatric Reviews Concept of Comprehensive Treatment for Osteoarthritis (OA)
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Mitochondrial Mutations in Atherosclerosis: New Solutions in Research and Possible Clinical Applications
Current Pharmaceutical Design Human Neural Stem and Progenitor Cells: In Vitro and In Vivo Properties, and Potential for Gene Therapy and Cell Replacement in the CNS
Current Gene Therapy Gene Therapy for the Peripheral Nervous System: A Strategy to Repair the Injured Nerve?
Current Gene Therapy ABC Transporters and Drug Resistance in Patients with Epilepsy
Current Pharmaceutical Design Rational Design and Development of RDP58
Current Pharmaceutical Design Oxytocin and Diabetes Mellitus: A Strong Biochemical Relation. Review
Current Diabetes Reviews Editorial (Thematic Issue: Myokines and Exercise Training: More Shadows than Lights)
Current Pharmaceutical Design The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind
Current Neuropharmacology Histone Deacetylase (HDAC) Inhibitors as Potential Drugs to Target Memory and Adult Hippocampal Neurogenesis
Current Psychopharmacology Silencing of Disease-related Genes by Small Interfering RNAs
Current Molecular Medicine